Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

June 7, 2022

Study Completion Date

May 9, 2025

Conditions
Cerebral Vein ThrombosisDeep Vein ThrombosisHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Malignant Solid NeoplasmPulmonary EmbolismSplanchnic Vein Thrombosis
Interventions
DRUG

Apixaban

Given PO

Trial Locations (32)

10467

Montefiore Medical Center - Moses Campus, The Bronx

20007

MedStar Georgetown University Hospital, Washington D.C.

27599

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

University of North Carolina, Chapel Hill

27710

Duke University Medical Center, Durham

28374

FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst

33331

Cleveland Clinic-Weston, Weston

41017

Saint Elizabeth Medical Center South, Edgewood

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

53226

Froedtert and the Medical College of Wisconsin LAPS, Milwaukee

Medical College of Wisconsin, Milwaukee

53717

Dean Hematology and Oncology Clinic, Madison

54449

Marshfield Medical Center-Marshfield, Marshfield

54701

Mayo Clinic Health System-Eau Claire Clinic, Eau Claire

55416

Metro Minnesota Community Oncology Research Consortium, Saint Louis Park

55905

Mayo Clinic in Rochester, Rochester

58201

Altru Cancer Center, Grand Forks

60201

NorthShore University HealthSystem-Evanston Hospital, Evanston

60611

Northwestern University, Chicago

61615

Illinois CancerCare-Peoria, Peoria

61801

Carle Cancer Center, Urbana

63110

Washington University School of Medicine, St Louis

67214

Cancer Center of Kansas - Wichita, Wichita

68198

University of Nebraska Medical Center, Omaha

85259

Mayo Clinic in Arizona, Scottsdale

98195

University of Washington Medical Center - Montlake, Seattle

32224-9980

Mayo Clinic in Florida, Jacksonville

02215

Dana-Farber Cancer Institute, Boston

03106

New Hampshire Oncology Hematology PA-Hooksett, Hooksett

03756

Dartmouth Hitchcock Medical Center, Lebanon

03103

Solinsky Center for Cancer Care, Manchester

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Academic and Community Cancer Research United

OTHER

NCT03080883 - Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy | Biotech Hunter | Biotech Hunter